Please login to the form below

Not currently logged in
Email:
Password:

drug shortage

This page shows the latest drug shortage news and features for those working in and with pharma, biotech and healthcare.

Not in my backyard

Not in my backyard

I think we’re all for lowering drug prices. And I know we’re all for helping patients access affordable medicine. ... The idea that one can turn to a neighbour for a solution is, at best, a short-term solution reserved for the most extreme cases like

Latest news

  • FDA launches drug shortages mobile app FDA launches drug shortages mobile app

    Valerie Jensen, associate director of the Drug Shortage Staff in the FDA's Center for Drug Evaluation and Research, said: “ The FDA understands that healthcare professionals and pharmacists need real-time ... The new mobile app is an innovative tool

  • EMA publishes European drug shortage details EMA publishes European drug shortage details

    EMA publishes European drug shortage details. First public list contains details on Cerezyme, Fabrazyme, Increlex and Vistide. ... product. Details include information on the reason for the shortage and the current status of supply.

  • FDA creates drug shortage plan FDA creates drug shortage plan

    FDA creates drug shortage plan. Manufacturers required to give early notice of potential shortfall of important medicines. ... called for in the Food and Drug Administration Safety and Innovation Act (FDASIA).

  • Swift US approval for Baxter’s nutritional supplement Swift US approval for Baxter’s nutritional supplement

    The approval comes after the drug received priority review status from the US regulator due to the shortage of products available for patients in this condition. ... There are a total of 242 products listed in the FDA' drug shortage list, 16 of which are

  • US shortage of GSK’s restless legs syndrome treatment Horizant US shortage of GSK’s restless legs syndrome treatment Horizant

    US shortage of GSK’ s restless legs syndrome treatment Horizant. FDA blames contract manufacturer delays. ... This saw a Complete Response Letter, declining to grant the drug marketing approval, issued in February 2010.

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics